Citadel Advisors’s Nexalin Technology NXL Stock Holding History

Citadel Advisors’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.9K	Buy	+2,513	New	+$31K	﹤0.01%	13354
2026 Q1	–	Sell	-1,030	Closed	-$17.2K	–	13839
2025 Q4	$17.2K	Buy	+1,030	New	+$34.7K	﹤0.01%	12371
2025 Q3	–	Sell	-1,243	Closed	-$38K	–	13702
2025 Q2	$38K	Buy	+1,243	New	+$52.4K	﹤0.01%	11899
2024 Q4	–	Sell	-1,940	Closed	-$38.9K	–	15116
2024 Q3	$38.9K	Buy	+1,940	New	+$60K	﹤0.01%	12169
2023 Q4	–	Sell	-502	Closed	-$6.67K	–	14936
2023 Q3	$6.67K	Buy	+502	New	+$9.43K	﹤0.01%	13307
2022 Q4	–	Sell	-516	Closed	-$17K	–	15272
2022 Q3	$17K	Buy	+516	New	+$21.2K	﹤0.01%	12132

Other funds holding NXL

PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Citadel Advisors's NXL Position: Q2 2026 in Review

Citadel Advisors opened a new position in Nexalin Technology (NXL) in Q2 2026: 2,513 shares worth $24.9K. The stake represents ﹤0.01% of the portfolio and ranks #13354 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NXL as recently as Q4 2025.

Citadel Advisors first reported a position in NXL in Q3 2022 and has held it in 6 quarters since. The position peaked at $38.9K in Q3 2024. 20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

Citadel Advisors held 2,513 shares of Nexalin Technology worth $24.9K as of Q2 2026.
Nexalin Technology was a new Citadel Advisors position in Q2 2026.
Nexalin Technology made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13354 holding.
Citadel Advisors first reported a position in Nexalin Technology in Q3 2022 and has held it in 6 quarters since.
Citadel Advisors's Nexalin Technology position peaked at $38.9K in Q3 2024.
20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.